BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 10629136)

  • 1. Evaluation of the BBL MGIT (Mycobacterial growth indicator tube) AST SIRE system for antimycobacterial susceptibility testing of Mycobacterium tuberculosis to 4 primary antituberculous drugs.
    Bergmann JS; Fish G; Woods GL
    Arch Pathol Lab Med; 2000 Jan; 124(1):82-6. PubMed ID: 10629136
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the ESP culture system II for testing susceptibilities of Mycobacterium tuberculosis isolates to four primary antituberculous drugs.
    Bergmann JS; Woods GL
    J Clin Microbiol; 1998 Oct; 36(10):2940-3. PubMed ID: 9738047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multicenter evaluation of the mycobacteria growth indicator tube for testing susceptibility of Mycobacterium tuberculosis to first-line drugs.
    Rüsch-Gerdes S; Domehl C; Nardi G; Gismondo MR; Welscher HM; Pfyffer GE
    J Clin Microbiol; 1999 Jan; 37(1):45-8. PubMed ID: 9854062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [BACTEC MGIT 960 system for drug susceptibility testing of Mycobacterium tuberculosis: a study using external quality assessment strains].
    Kobayashi I; Abe C; Mitarai S
    Kekkaku; 2006 Feb; 81(2):57-62. PubMed ID: 16529006
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mycobacterial growth indicator tube for susceptibility testing of Mycobacterium tuberculosis to isoniazid and rifampin.
    Bergmann JS; Woods GL
    Diagn Microbiol Infect Dis; 1997 Jul; 28(3):153-6. PubMed ID: 9294706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapid phenotypic assay of antimycobacterial susceptibility pattern by direct mycobacteria growth indicator tube and phage amplified biological assay compared to BACTEC 460 TB.
    El-Sayed Zaki M; Goda T
    Tuberculosis (Edinb); 2007 Mar; 87(2):102-8. PubMed ID: 17035089
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Testing of susceptibility of Mycobacterium tuberculosis to isoniazid and rifampin by mycobacterium growth indicator tube method.
    Walters SB; Hanna BA
    J Clin Microbiol; 1996 Jun; 34(6):1565-7. PubMed ID: 8735121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antimicrobial susceptibility testing of Mycobacterium tuberculosis to first-line drugs: comparisons of the MGIT 960 and BACTEC 460 systems.
    Huang TS; Tu HZ; Lee SS; Huang WK; Liu YC
    Ann Clin Lab Sci; 2002; 32(2):142-7. PubMed ID: 12017195
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reliability of mycobacteria growth indicator tube for testing susceptibility of Mycobacterium tuberculosis to ethambutol and streptomycin.
    Bergmann JS; Woods GL
    J Clin Microbiol; 1997 Dec; 35(12):3325-7. PubMed ID: 9399548
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Evaluation of the BACTEC MGIT 960 system for drug susceptibility testing of Mycobacterium tuberculosis isolates compared with the proportion method on solid media].
    Abe C; Aono A; Hirano K
    Kekkaku; 2001 Oct; 76(10):657-62. PubMed ID: 11712386
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapid susceptibility testing of Mycobacterium tuberculosis by the Mycobacteria Growth Indicator Tube (MGIT AST SIRE).
    Macondo EA; Ba F; Gaye-Diallo A; Touré-Kane NC; Kaïré O; Gueye-Ndiaye A; Boye CS; Mboup S
    Clin Microbiol Infect; 2000 Jul; 6(7):363-7. PubMed ID: 11168152
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the fully automated Bactec MGIT 960 system for the susceptibility testing of Mycobacterium tuberculosis to first-line drugs: a multicenter study.
    Kontos F; Maniati M; Costopoulos C; Gitti Z; Nicolaou S; Petinaki E; Anagnostou S; Tselentis I; Maniatis AN
    J Microbiol Methods; 2004 Feb; 56(2):291-4. PubMed ID: 14744458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Performance of microscopic observation drug susceptibility for the rapid diagnosis of tuberculosis and detection of drug resistance in Bamako, Mali.
    Sanogo M; Kone B; Diarra B; Maiga M; Baya B; Somboro AM; Sarro YS; Togo ACG; Dembele BPP; Goita D; Kone A; M'Baye O; Coulibaly N; Diabate S; Traore B; Diallo MH; Coulibaly YI; Saleeb P; Belson M; Orsega S; Siddiqui S; Polis MA; Dao S; Murphy RL; Diallo S
    Clin Microbiol Infect; 2017 Jun; 23(6):408.e1-408.e6. PubMed ID: 28110049
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of mycobacteria growth indicator tubes for susceptibility testing of Mycobacterium tuberculosis to isoniazid and rifampin.
    Reisner BS; Gatson AM; Woods GL
    Diagn Microbiol Infect Dis; 1995 Aug; 22(4):325-9. PubMed ID: 8582137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Testing of Mycobacterium tuberculosis susceptibility to ethambutol, isoniazid, rifampin, and streptomycin by using Etest.
    Wanger A; Mills K
    J Clin Microbiol; 1996 Jul; 34(7):1672-6. PubMed ID: 8784567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the Commercial Kit SIRE Nitratase for detecting resistant Mycobacterium tuberculosis in Brazil.
    Miranda SS; Almeida IN; Lopes ML; Figueiredo JDR; Figueredo LJA; Kritski AL; Carvalho WDS; Mansur MFFO
    Rev Soc Bras Med Trop; 2017; 50(4):550-553. PubMed ID: 28954080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multicenter laboratory evaluation of the MB/BacT Mycobacterium detection system and the BACTEC MGIT 960 system in comparison with the BACTEC 460TB system for susceptibility testing of Mycobacterium tuberculosis.
    Garrigó M; Aragón LM; Alcaide F; Borrell S; Cardeñosa E; Galán JJ; Gonzalez-Martín J; Martin-Casabona N; Moreno C; Salvado M; Coll P
    J Clin Microbiol; 2007 Jun; 45(6):1766-70. PubMed ID: 17442793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of line probe assay to BACTEC MGIT 960 system for susceptibility testing of first and second-line anti-tuberculosis drugs in a referral laboratory in South Africa.
    Maningi NE; Malinga LA; Antiabong JF; Lekalakala RM; Mbelle NM
    BMC Infect Dis; 2017 Dec; 17(1):795. PubMed ID: 29282012
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapid, automated, nonradiometric susceptibility testing of Mycobacterium tuberculosis complex to four first-line antituberculous drugs used in standard short-course chemotherapy.
    Johansen IS; Thomsen VØ; Marjamäki M; Sosnovskaja A; Lundgren B
    Diagn Microbiol Infect Dis; 2004 Oct; 50(2):103-7. PubMed ID: 15474318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the fully automated BACTEC MGIT 960 system for testing susceptibility of Mycobacterium tuberculosis to pyrazinamide, streptomycin, isoniazid, rifampin, and ethambutol and comparison with the radiometric BACTEC 460TB method.
    Scarparo C; Ricordi P; Ruggiero G; Piccoli P
    J Clin Microbiol; 2004 Mar; 42(3):1109-14. PubMed ID: 15004061
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.